Diantha Duvall Insider Trading $BIVV Bioverativ Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Diantha Duvall.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Diantha Duvall. Diantha Duvall is CHIEF FINANCIAL OFFICER in GENOCEA BIOSCIENCES, INC. ($GNCA) and Chief Accounting Officer in Bioverativ Inc. ($BIVV).
Diantha Duvall in Bioverativ Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Diantha Duvall: Chief Accounting Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 08 2018
$BIVV Market Capitalization: $4637.62B
$BIVV Previous Close: $44.44
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Diantha Duvall in Bioverativ Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 08 2018 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Option Exercise | D | 44.51 | 11,062 | 492,370 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Option Exercise | D | 52.08 | 7,030 | 366,122 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Option Exercise | D | 0.00 | 7,273 | 0 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Option Exercise | D | 0.00 | 2,780 | 0 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Sell | D | 0.00 | 2,791 | 0 | 0 | 2.8 K to 0 (-100.00 %) |
| Mar 05 2018 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Payment of Exercise | F | 104.73 | 105 | 10,997 | 2,791 | 2.9 K to 2.8 K (-3.63 %) |
| Feb 26 2018 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Payment of Exercise | F | 104.30 | 168 | 17,522 | 2,896 | 3.1 K to 2.9 K (-5.48 %) |
| Feb 15 2018 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Option Exercise | M | 0.00 | 1,390 | 0 | 2,780 | |
| Feb 15 2018 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Payment of Exercise | F | 103.52 | 454 | 46,998 | 3,064 | 3.5 K to 3.1 K (-12.91 %) |
| Feb 15 2018 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Buy | M | 0.00 | 1,390 | 0 | 3,518 | 2.1 K to 3.5 K (+65.32 %) |
| Jun 29 2017 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Sell | S | 60.47 | 818 | 49,464 | 2,128 | 2.9 K to 2.1 K (-27.77 %) |
| May 03 2017 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Payment of Exercise | F | 57.48 | 99 | 5,691 | 2,946 | 3 K to 2.9 K (-3.25 %) |
| Mar 03 2017 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Payment of Exercise | F | 52.81 | 113 | 5,968 | 3,045 | 3.2 K to 3 K (-3.58 %) |
| Feb 16 2017 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Option Exercise | A | 44.51 | 11,043 | 491,524 | 11,043 | |
| Feb 16 2017 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Option Exercise | A | 44.51 | 11,043 | 491,524 | 11,043 | |
| Feb 16 2017 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Option Exercise | A | 0.00 | 4,170 | 0 | 4,170 | |
| Feb 16 2017 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Option Exercise | A | 0.00 | 4,170 | 0 | 4,170 |
Page: 1